Kill502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo

by Nishioka, C, Ikezoe, T, Yang, J, Miwa, A, Tasaka, T, Kuwayama, Y, Togitani, K, Koeffler, H.P, Yokoyama, A
Published 2020

Expression of p-JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia

by Ikezoe, T., Kojima, S., Furihata, M., Yang, J., Nishioka, C., Takeuchi, A., Isaka, M., Koeffler, H.P., Yokoyama, A.
Published 2016